| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |